Literature DB >> 30361856

Gastric Cancer: an Evolving Disease.

Minkyo Song1, Charles S Rabkin1, M Constanza Camargo2.   

Abstract

PURPOSE OF REVIEW: Prevalence of Helicobacter pylori, the primary risk factor for gastric cancer, is declining globally. Paralleling this trend, gastric cancer incidence is also decreasing. Historically, the populations most affected by this neoplasia have been males, Asians, and groups with low socioeconomic status. This review provides an update on recently published literature regarding changes in gastric cancer epidemiology. RECENT
FINDINGS: Gastric cancer incidence trends vary by age, sex, race/ethnicity, and tumor anatomical location. Overall incidence appears to be leveling off among young birth cohorts in Western populations, where H. pylori has declined considerably. The changes are more prominent for females and for tumors arising beyond the esophageal-gastric junction. The classical incidence pattern of gastric cancer is evolving. While uncertain, several hypotheses may explain the changing burden of disease. The mix of gastric cancer risk factors appears to be shifting, with H. pylori no longer the sole etiological driver. These changes may eliminate the previous predilection of males and lead to increases in overall gastric cancer rates. Analytical studies addressing known and novel factors related to major societal transitions may provide clues to understanding re-emergence of this serious public health problem.

Entities:  

Keywords:  Autoimmune gastritis; Gastric cancer epidemiology; Helicobacter pylori; Incidence trends

Year:  2018        PMID: 30361856      PMCID: PMC7453722          DOI: 10.1007/s11938-018-0203-1

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  55 in total

1.  Height, weight, and body mass index associations with gastric cancer subsites.

Authors:  M Constanza Camargo; Neal D Freedman; Albert R Hollenbeck; Christian C Abnet; Charles S Rabkin
Journal:  Gastric Cancer       Date:  2013-10-31       Impact factor: 7.370

2.  Global patterns and trends in stomach cancer incidence: Age, period and birth cohort analysis.

Authors:  Ganfeng Luo; Yanting Zhang; Pi Guo; Li Wang; Yuanwei Huang; Ke Li
Journal:  Int J Cancer       Date:  2017-06-27       Impact factor: 7.396

Review 3.  Helicobacter pylori and autoimmune disease: cause or bystander.

Authors:  Daniel S Smyk; Andreas L Koutsoumpas; Maria G Mytilinaiou; Eirini I Rigopoulou; Lazaros I Sakkas; Dimitrios P Bogdanos
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

4.  Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site.

Authors:  Hongyu Wu; Jennifer A Rusiecki; Kangmin Zhu; John Potter; Susan S Devesa
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-16       Impact factor: 4.254

5.  Can pre-neoplastic lesions be detected in gastric biopsies of children with Helicobacter pylori infection?

Authors:  Jeannette Guarner; Jeanine Bartlett; Toni Whistler; Daphne Pierce-Smith; Marilyn Owens; Rachel Kreh; Steven Czinn; Benjamin D Gold
Journal:  J Pediatr Gastroenterol Nutr       Date:  2003-09       Impact factor: 2.839

6.  Time trend in the prevalence of intestinal metaplasia in Japan.

Authors:  T Imai; H Murayama
Journal:  Cancer       Date:  1983-07-15       Impact factor: 6.860

7.  Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies.

Authors:  Yi Chen; Lingxiao Liu; Xiaolin Wang; Jianhua Wang; Zhiping Yan; Jieming Cheng; Gaoquan Gong; Guoping Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-05-22       Impact factor: 4.254

Review 8.  Obesity and related risk factors in gastric cardia adenocarcinoma.

Authors:  Sidney Olefson; Steven F Moss
Journal:  Gastric Cancer       Date:  2014-09-11       Impact factor: 7.370

9.  Acid-suppressing therapies and subsite-specific risk of stomach cancer.

Authors:  E Christina M Wennerström; Jacob Simonsen; M Constanza Camargo; Charles S Rabkin
Journal:  Br J Cancer       Date:  2017-03-28       Impact factor: 7.640

Review 10.  Autoimmune atrophic gastritis: current perspectives.

Authors:  Artem Minalyan; Jihane N Benhammou; Aida Artashesyan; Michael S Lewis; Joseph R Pisegna
Journal:  Clin Exp Gastroenterol       Date:  2017-02-07
View more
  15 in total

1.  Qi Ling decoction reduces gastric cancer cell metastasis by inhibiting MMP-9 through the PI3K/Akt signaling pathway.

Authors:  Wen Chen; Yuheng Zhang; Xiaoqun Gu; Peiyao Qian; Wanli Liu; Peng Shu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  Associations Between Autoimmune Conditions and Gastric Cancer Risk Among Elderly Adults in the United States.

Authors:  Minkyo Song; M Constanza Camargo; Andriy Derkach; Charles S Rabkin; Eric A Engels
Journal:  Am J Gastroenterol       Date:  2022-03-01       Impact factor: 12.045

3.  Evaluation of Important Molecular Pathways and Candidate Diagnostic Biomarkers of Noninvasive to Invasive Stages in Gastric Cancer by In Silico Analysis.

Authors:  Sara Tutunchi; Saeedeh Akhavan; Ahmad Bereimipour; Sayyed Mohammad Hossein Ghaderian
Journal:  J Oncol       Date:  2021-05-07       Impact factor: 4.375

4.  CircMAN1A2 is upregulated by Helicobacter pylori and promotes development of gastric cancer.

Authors:  Ruiting Guo; Xixi Cui; Xue Li; Wen Zang; Mingjie Chang; Zenghui Sun; Zhifang Liu; Yundong Sun; Jihui Jia; Wenjuan Li
Journal:  Cell Death Dis       Date:  2022-04-28       Impact factor: 9.685

5.  Radiofrequency ablation versus traditional liver resection and chemotherapy for liver metastases from gastric cancer.

Authors:  Kezhong Tang; Bo Zhang; Linping Dong; Lantian Wang; Zhe Tang
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

6.  Psychological effects of advanced care on patients received endoscopic gastric cancer resection.

Authors:  Xiao-Li Cao; Xin Wang; Ping Li; Wei Ju
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

7.  Identification of novel hub genes associated with gastric cancer using integrated bioinformatics analysis.

Authors:  Xiao-Qing Lu; Jia-Qian Zhang; Sheng-Xiao Zhang; Jun Qiao; Meng-Ting Qiu; Xiang-Rong Liu; Xiao-Xia Chen; Chong Gao; Huan-Hu Zhang
Journal:  BMC Cancer       Date:  2021-06-14       Impact factor: 4.430

8.  Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217).

Authors:  Joseph Tintelnot; Eray Goekkurt; Mascha Binder; Peter Thuss-Patience; Sylvie Lorenzen; Jorge Riera Knorrenschild; Albrecht Kretzschmar; Thomas Ettrich; Udo Lindig; Lutz Jacobasch; Daniel Pink; Salah-Eddin Al-Batran; Axel Hinke; Susanna Hegewisch-Becker; Sven Nilsson; Carsten Bokemeyer; Alexander Stein
Journal:  BMC Cancer       Date:  2020-06-01       Impact factor: 4.430

9.  Toll-like receptor 9 polymorphisms and Helicobacter pylori influence gene expression and risk of gastric carcinogenesis in the Brazilian population.

Authors:  Manoela Dias Susi; de Matos Lourenço Caroline; Lucas Trevizani Rasmussen; Spencer Luis Marques Payão; Ana Flávia Teixeira Rossi; Ana Elizabete Silva; Juliana Garcia de Oliveira-Cucolo
Journal:  World J Gastrointest Oncol       Date:  2019-11-15

10.  miR-100-3p inhibits cell proliferation and induces apoptosis in human gastric cancer through targeting to BMPR2.

Authors:  Chun-Wei Peng; Ling-Xiao Yue; Yuan-Qin Zhou; Sai Tang; Chen Kan; Lei-Ming Xia; Fan Yang; Si-Ying Wang
Journal:  Cancer Cell Int       Date:  2019-12-27       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.